Pharma Equity Group A/S Sustainability Reports

Pharma Equity Group A/S is a Danish life science investment company focused on the pharmaceutical and healthcare industries. Its primary activity is the clinical advancement of therapeutic projects through its fully-owned drug development subsidiary, Reponex Pharmaceuticals A/S.

Sector: Finance & insurance

Country: Denmark

Exchange: Nasdaq Copenhagen

LEI: 2138008SUI4D917FKN20

FIGI: BBG001SLPJR2

12 reports from 2013 to 2025

• Pharma Equity Group A/S 2025 Annual Report
• Pharma Equity Group A/S 2024 Annual Report
• Pharma Equity Group A/S 2023 Corporate Governance Report
• Pharma Equity Group A/S 2023 Annual Report
• Pharma Equity Group A/S 2022 Annual Report